Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development
Pralay Mukhopadhyay, Hesham Abdullah, Joanna Opalinska, Prani Paka, Eric Richards, Katja Weisel, Suzanne Trudel, María‐Victoria Mateos, Meletios A Dimopoulos, Sagar Lonial (2025). The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development. , 15(1), DOI: https://doi.org/10.1038/s41408-025-01212-0.
Article24 days agoIsatuximab for the treatment of multiple myeloma: current clinical advances and future directions
Paul G. Richardson, Elisabeth K. O’Donnell, Peter O’Gorman, Lisa Leypoldt, Jacob P. Laubach, Francesca Gay, Xavier Leleu, Thierry Façon, Philippe Moreau, Meletios A Dimopoulos, Hartmut Goldschmidt, K. Elias, Michèle Cavo, Katja Weisel, Jesús G. Berdeja, Robert Z. Orlowski, Meral Beksaç, Aurore Perrot, Joseph Mıkhael, T. John Martin (2025). Isatuximab for the treatment of multiple myeloma: current clinical advances and future directions. , 34(7-8), DOI: https://doi.org/10.1080/13543784.2025.2532446.
Article24 days agoPractical Guidance on Clinical Management of Belantamab Mafodotin‐Associated Ocular Events
Evangelos Terpos, Suzanne Trudel, María‐Victoria Mateos, Nicolás Alejandre, Kathryn Colby, Meletios A Dimopoulos, Simona Degli Esposti, Asim V. Farooq, Maria Gavriatopoulou, Francesca Gay, Vânia Hungria, K. Martin Kortüm, Xavier Leleu, Sagar Lonial, Hang Quach, Lugui Qiu, Karthik Ramasamy, Kazuhito Suzuki, Katja Weisel, Paul G. Richardson (2025). Practical Guidance on Clinical Management of Belantamab Mafodotin‐Associated Ocular Events. , 100(10), DOI: https://doi.org/10.1002/ajh.70015.
Article24 days agoCorrection: The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development
Pralay Mukhopadhyay, Hesham Abdullah, Joanna Opalinska, Prani Paka, Eric Richards, Katja Weisel, Suzanne Trudel, María‐Victoria Mateos, Meletios A Dimopoulos, Sagar Lonial (2025). Correction: The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development. , 15 (1), DOI: https://doi.org/10.1038/s41408-025-01243-7.
Corrigendum24 days agoEHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma
Meletios A Dimopoulos, Evangelos Terpos, Mario Boccadoro, Philippe Moreau, María‐Victoria Mateos, Sonja Zweegman, Gordon Cook, Monika Engelhardt, Michel Delforge, Roman Hájek, Fredrik Schjesvold, Francesca Gay, Morten Salomo, Katja Weisel, Martin Kaiser, Niels W.C.J. van de Donk, Elena Zamagni, Paula Rodríguez‐Otero, Aurore Perrot, Christoph Driessen, Jelena Bila, Edward Laane, Dominik Dytfeld, Cyrille Touzeau, Meral Beksac, Marc S. Raab, Michèle Cavo, Mohamad Mohty, Andrew Spencer, Heinz Ludwig, Hermann Einsele, Jesús F. San Miguel, Pieter Sonneveld (2025). EHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma. , 22(9), DOI: https://doi.org/10.1038/s41571-025-01041-x.
Article24 days ago